{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:27Z","timestamp":1787024667768,"version":"build-2736575974"},"reference-count":148,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Diabetic foot ulcer (DFU) is one of the leading complications of type-2 diabetes\nmellitus. It is associated with neuropathy and peripheral arterial disease of the lower limb in\npatients with diabetes. There are four stages of wound healing, namely hemostasis phase, inflammatory\nphase, proliferative phase and maturation phase. In the case of DFU, all these stages are disturbed\nwhich lead to delay in healing and consequently to lower limb amputation. Conventional\ndosage forms like tablets, creams, ointments, gels and capsules have been used for the treatment of\ndiabetic foot ulcer for many years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>In this review, the global prevalence as well as etiopathogenesis related to diabetic\nfoot ulcer have been discussed. The potential role of various synthetic and herbal drugs, as well as\ntheir conventional dosage forms in the effective management of DFU have been discussed in detail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Structured search of bibliographic databases from previously published peer-reviewed research\npapers was explored and data has been represented in terms of various approaches that are\nused for the treatment of DFU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>About 148 papers, including both research and review articles, were included in this review\nto produce a comprehensive as well as a readily understandable article. A series of herbal and\nsynthetic drugs have been discussed along with their current status of treatment in terms of dose\nand mechanism of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>DFU has become one of the most common complications in patients having diabetes\nfor more than ten years. Hence, understanding the root cause and its successful treatment is a big\nchallenge because it depends upon multiple factors such as the judicious selection of drugs as well\nas proper control of blood sugar level. Most of the drugs that have been used so far either belong to\nthe category of antibiotics, antihyperglycaemic or they have been repositioned. In clinical practice,\nmuch focus has been given to dressings that have been used to cover the ulcer. The complete treatment\nof DFU is still a farfetched dream to be achieved and it is expected that combination therapy\nof herbal and synthetic drugs with multiple treatment pathways could be able to offer better management\nof DFU.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1573399816999201102125537","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T02:54:51Z","timestamp":1604458491000},"page":"421-436","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-7649","authenticated-orcid":true,"given":"Ankit","family":"Awasthi","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3823-6572","authenticated-orcid":true,"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-5172","authenticated-orcid":true,"given":"Bimlesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-5162","authenticated-orcid":true,"given":"Monica","family":"Gulati","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1489-8144","authenticated-orcid":true,"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6714-9817","authenticated-orcid":true,"given":"Sheetu","family":"Wadhwa","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-419X","authenticated-orcid":true,"given":"Rubiya","family":"Khursheed","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1626-3513","authenticated-orcid":true,"given":"Leander","family":"Corrie","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7608-0081","authenticated-orcid":true,"given":"Arya","family":"KR","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-1816","authenticated-orcid":true,"given":"Rajan","family":"Kumar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-782X","authenticated-orcid":true,"given":"Pooja","family":"Patni","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-7186","authenticated-orcid":true,"given":"Jaskiran","family":"Kaur","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-1898","authenticated-orcid":true,"given":"Sukriti","family":"Vishwas","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-4206","authenticated-orcid":true,"given":"Ankit","family":"Yadav","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Lovely Professional University Phagwara, 144411, Punjab,India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"34","volume":"14","author":"Radhakrishna K.","year":"2014","unstructured":"Radhakrishna K.; VVS NRK BM, Kuppusamy G. Potential use of herbal medicines in the treatment of diabetic foot ulcers. History (Lond) 2014,14(56),34-42","journal-title":"History (Lond)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.11124\/JBISRIR-2016-002958","volume":"15","author":"Kaur N.","year":"2017","unstructured":"Kaur N.; Fernandez R.; Sim J.; Effect of Aloe vera on glycemic outcomes in patients with diabetes mellitus: a systematic review protocol. JBI Database Syst Rev Implement Reports 2017,15(9),2300-2306","journal-title":"JBI Database Syst Rev Implement Reports"},{"key":"ref=3","first-page":"579","volume":"140","author":"Ramachandran A.","year":"2014","unstructured":"Ramachandran A.; Know the signs and symptoms of diabetes. Indian J Med Res 2014,140(5),579-581","journal-title":"Indian J Med Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"Kitabchi A.E.","year":"2009","unstructured":"Kitabchi A.E.; Umpierrez G.E.; Miles J.M.; Fisher J.N.; Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009,32(7),1335-1343","journal-title":"Diabetes Care"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13300-012-0004-9","volume":"3","author":"Alexiadou K.","year":"2012","unstructured":"Alexiadou K.; Doupis J.; Management of diabetic foot ulcers. Diabetes Ther 2012,3(1),4","journal-title":"Diabetes Ther"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/wound.2018.0831","volume":"8","author":"Natarajan J.","year":"2019","unstructured":"Natarajan J.; Sanapalli B.K.R.; Bano M.; Singh S.K.; Gulati M.; Karri V.V.S.R.; Nanostructured Lipid Carriers of Pioglitazone Loaded Collagen\/Chitosan Composite Scaffold for Diabetic Wound Healing. Adv Wound Care (New Rochelle) 2019,8(10),499-513","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/01.JAA.0000464276.44117.b1","volume":"28","author":"Aumiller W.D.","year":"2015","unstructured":"Aumiller W.D.; Dollahite H.A.; Pathogenesis and management of diabetic foot ulcers. JAAPA 2015,28(5),28-34","journal-title":"JAAPA"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","volume":"128","author":"Ogurtsova K.","year":"2017","unstructured":"Ogurtsova K.; da Rocha Fernandes J.D.; Huang Y.; Linnenkamp U.; Guariguata L.; Cho N.H.; Cavan D.; Shaw J.E.; Makaroff L.E.; IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017,128,40-50","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.11648\/j.ijde.20180302.11","volume":"3","author":"Ibrahim A.M.","year":"2018","unstructured":"Ibrahim A.M.; Diabetic Foot Ulcer: Synopsis of the Epidemiology and Pathophysiology. Int J Diabetes Endocrin 2018,3(2),23","journal-title":"Int J Diabetes Endocrin"},{"key":"ref=10","first-page":"5","author":"Bus S.A.","year":"2019","unstructured":"Bus S.A.; Lavery L.; Monteiro-Soares M.; Rasmussen A.; Raspovic A.; Sacco I.; IWGDF Guideline on the prevention of foot ulcers in persons with diabetes. Diabetes Metab Res Rev 2019,5-67","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.diabres.2017.04.013","volume":"127","author":"Ibrahim A.","year":"2017","unstructured":"Ibrahim A.; IDF clinical practice recommendation on the diabetic foot: a guide for healthcare professionals. diabetes research and clinical practice 2017,127,285-7","journal-title":"diabetes research and clinical practice"},{"key":"ref=12","author":"Murphy-Lavoie H.M.","year":"2017","unstructured":"Murphy-Lavoie H.M.; Bhimji S.S.;  Diabetic, Foot Infections 2017","journal-title":"Diabetic, Foot Infections"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"A485","DOI":"10.1016\/j.jval.2017.08.489","volume":"20","author":"Ghosh P.","year":"2017","unstructured":"Ghosh P.; Valia R.; Burden of Diabetic Foot Ulcers in India: Evidence Landscape from Published Literature. Value Health 2017,20(9),A485","journal-title":"Value Health"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12902-018-0270-2","volume":"18","author":"Vibha S.P.","year":"2018","unstructured":"Vibha S.P.; Kulkarni M.M.; Kirthinath Ballala A.B.; Kamath A.; Maiya G.A.; Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocr Disord 2018,18(1),43","journal-title":"BMC Endocr Disord"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/dme.13512","volume":"35","author":"Paisey R.B.","year":"2018","unstructured":"Paisey R.B.; Abbott A.; Levenson R.; Harrington A.; Browne D.; Moore J.; Bamford M.; Roe M.; Diabetes-related major lower limb amputation incidence is strongly related to diabetic foot service provision and improves with enhancement of services: peer review of the South-West of England. Diabet Med South-West Cardiovascular Strategic Clinical Network peer diabetic foot service review team2018,35(1),53-62","journal-title":"Diabet Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781119445821.ch1","author":"Boyko E.J.","year":"2020","unstructured":"Boyko E.J.; Monteiro-Soares M.;  Epidemiology and Economic Impact of Foot Ulcers.  The Foot in Diabet 2020,1-15","journal-title":"The Foot in Diabet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07853890.2016.1231932","volume":"49","author":"Zhang P.","year":"2017","unstructured":"Zhang P.; Lu J.; Jing Y.; Tang S.; Zhu D.; Bi Y.; Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis . Ann Med 2017,49(2),106-116","journal-title":"Ann Med"},{"key":"ref=18","author":"Orsted H.","year":"2018","unstructured":"Orsted H.; Keast D.; Forest-Laland L.; Kuhnke J.; O\u2019Sullivan-Drombolis D.; Jin S.; Foundations of best practice for skin and wound management.  Chapter 2 Best practice recommendations for the prevention and management of wounds 2018","journal-title":"Chapter 2 Best practice recommendations for the prevention and management of wounds"},{"key":"ref=19","first-page":"40","volume":"6","author":"Ahmed A.A.","year":"2014","unstructured":"Ahmed A.A.; Algamdi S.A.; Algurashi A.; Alzhrani A.M.; Khalid K.A.; Risk factors for diabetic foot ulceration among patients attending primary health care services. J Diabet Foot Complications 2014,6,40-47","journal-title":"J Diabet Foot Complications"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.biopha.2016.11.118","volume":"85","author":"G S.B.","year":"2017","unstructured":"G S.B.; Choi S.; Krishnan J.; K R.; Cigarette smoke and related risk factors in neurological disorders: An update. Biomed Pharmacother 2017,85,79-86","journal-title":"Biomed Pharmacother"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/hc0702.103977","volume":"105","author":"Knight-Lozano C.A.","year":"2002","unstructured":"Knight-Lozano C.A.; Young C.G.; Burow D.L.; Hu Z.Y.; Uyeminami D.; Pinkerton K.E.; Ischiropoulos H.; Ballinger S.W.; Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002,105(7),849-854","journal-title":"Circulation"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/1055-9965.EPI-05-0210","volume":"15","author":"Masayesva B.G.","year":"2006","unstructured":"Masayesva B.G.; Mambo E.; Taylor R.J.; Goloubeva O.G.; Zhou S.; Cohen Y.; Minhas K.; Koch W.; Sciubba J.; Alberg A.J.; Sidransky D.; Califano J.; Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev 2006,15(1),19-24","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1096\/fj.04-2591hyp","volume":"19","author":"Lee J-M.","year":"2005","unstructured":"Lee J-M.; Li J.; Johnson D.A.; Stein T.D.; Kraft A.D.; Calkins M.J.; Jakel R.J.; Johnson J.A.; Nrf2, a multi-organ protector? FASEB J 2005,19(9),1061-1066","journal-title":"FASEB J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"22S","DOI":"10.1016\/0002-9343(92)90623-J","volume":"93","author":"Silverstein P.","year":"1992","unstructured":"Silverstein P.; Smoking and wound healing. Am J Med 1992,93(1A),22S-24S","journal-title":"Am J Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1367210","DOI":"10.1080\/2000625X.2017.1367210","volume":"8","author":"Cervantes-Garc&#xED;a E.","year":"2017","unstructured":"Cervantes-Garc&#xED;a E.; Salazar-Schettino P.M.; Clinical and surgical characteristics of infected diabetic foot ulcers in a tertiary hospital of Mexico. Diabet Foot Ankle 2017,8(1),1367210","journal-title":"Diabet Foot Ankle"},{"key":"ref=26","first-page":"150","volume":"5","author":"Mooradian A.D.","year":"2009","unstructured":"Mooradian A.D.; Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009,5(3),150-159","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2337\/diabetes.50.2.315","volume":"50","author":"Briaud I.","year":"2001","unstructured":"Briaud I.; Harmon J.S.; Kelpe C.L.; Segu V.B.G.; Poitout V.; Lipotoxicity of the pancreatic &#x3B2;-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes 2001,50(2),315-321","journal-title":"Diabetes"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1073\/pnas.91.23.10878","volume":"91","author":"Lee Y.","year":"1994","unstructured":"Lee Y.; Hirose H.; Ohneda M.; Johnson J.H.; McGarry J.D.; Unger R.H.; Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte- beta-cell relationships. Proc Natl Acad Sci USA 1994,91(23),10878-10882","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e0172221","DOI":"10.1371\/journal.pone.0172221","volume":"12","author":"Zheng S.","year":"2017","unstructured":"Zheng S.; Xu H.; Zhou H.; Ren X.; Han T.; Chen Y.; Qiu H.; Wu P.; Zheng J.; Wang L.; Liu W.; Hu Y.; Associations of lipid profiles with insulin resistance and &#x3B2; cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation. PLoS One 2017,12(2),e0172221","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/B978-0-12-800101-1.00008-9","author":"Rachek L.I.","year":"2014","unstructured":"Rachek L.I.;  Progress in molecular biology and translational science 2014,267-292","journal-title":"Progress in molecular biology and translational science"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","volume":"86","author":"Goldberg I.J.","year":"2001","unstructured":"Goldberg I.J.; Clinical review 124: Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001,86(3),965-971","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","volume":"27","author":"Krauss R.M.","year":"2004","unstructured":"Krauss R.M.; Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004,27(6),1496-1504","journal-title":"Diabetes Care"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"E1245","DOI":"10.1210\/jc.2013-3463","volume":"99","author":"Verg&#xE8;s B.","year":"2014","unstructured":"Verg&#xE8;s B.; Duvillard L.; Lagrost L.; Vachoux C.; Garret C.; Bouyer K.; Courtney M.; Pomi&#xE9; C.; Burcelin R.; Changes in lipoprotein kinetics associated with type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins. J Clin Endocrinol Metab 2014,99(7),E1245-E1253","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc16-1958","volume":"40","author":"Lee J.S.","year":"2017","unstructured":"Lee J.S.; Chang P-Y.; Zhang Y.; Kizer J.R.; Best L.G.; Howard B.V.; Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study. Diabetes Care 2017,40(4),529-537","journal-title":"Diabetes Care"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1751-7176.2009.00179.x","volume":"11","author":"Giles T.D.","year":"2009","unstructured":"Giles T.D.; Materson B.J.; Cohn J.N.; Kostis J.B.; Definition and classification of hypertension: an update. J Clin Hypertens (Greenwich) 2009,11(11),611-614","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"c1104","DOI":"10.1136\/bmj.c1104","volume":"340","author":"Head G.A.","year":"2010","unstructured":"Head G.A.; Mihailidou A.S.; Duggan K.A.; Beilin L.J.; Berry N.; Brown M.A.; Bune A.J.; Cowley D.; Chalmers J.P.; Howe P.R.; Hodgson J.; Ludbrook J.; Mangoni A.A.; McGrath B.P.; Nelson M.R.; Sharman J.E.; Stowasser M.; Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ Ambulatory blood pressure working group of the high blood pressure research council of australia2010,340,c1104","journal-title":"BMJ"},{"key":"ref=37","first-page":"207","volume":"25","author":"Greco D.","year":"1995","unstructured":"Greco D.; Sinagra D.; Hyperinsulinism\/insulin resistance: cause, effect or marker of essential arterial hypertension? G Ital Cardiol 1995,25(2),207-216","journal-title":"G Ital Cardiol"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00026.2004","author":"Sowers J.R.","year":"2004","unstructured":"Sowers J.R.; Insulin resistance and hypertension. American Physiological Society 2004","journal-title":"American Physiological Society"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-5996-6-12","volume":"6","author":"Zhou M-S.","year":"2014","unstructured":"Zhou M-S.; Wang A.; Yu H.; Link between insulin resistance and hypertension: What is the evidence from evolutionary biology? Diabetol Metab Syndr 2014,6(1),12","journal-title":"Diabetol Metab Syndr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2165\/00003495-199300462-00024","volume":"46","author":"Salvetti A.","year":"1993","unstructured":"Salvetti A.; Brogi G.; Di Legge V.; Bernini G.P.; The inter-relationship between insulin resistance and hypertension. Drugs 1993,46(2)(Suppl. 2),149-159","journal-title":"Drugs"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e23224","DOI":"10.1371\/journal.pone.0023224","volume":"6","author":"Ahmed A.A.","year":"2011","unstructured":"Ahmed A.A.; Mooar P.A.; Kleiner M.; Torg J.S.; Miyamoto C.T.; Hypertensive patients show delayed wound healing following total hip arthroplasty. PLoS One 2011,6(8),e23224","journal-title":"PLoS One"},{"key":"ref=42","author":"Papatheodorou K","unstructured":"Papatheodorou K; Banach M; Bekiari E; Rizzo M; Edmonds M.; Complications of diabetes 2017. J Diabet Res 2018; 2018: 3086167.","journal-title":"J Diabet Res"},{"key":"ref=43","author":"Papatheodorou K","unstructured":"Papatheodorou K; Papanas N; Banach M; Papazoglou D; Edmonds M.; Complications of diabetes 2016. J Diabet Res 2016; 2016: 6989453.","journal-title":"J Diabet Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","volume":"2","author":"Yagihashi S.","year":"2011","unstructured":"Yagihashi S.; Mizukami H.; Sugimoto K.; Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig 2011,2(1),18-32","journal-title":"J Diabetes Investig"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e0175270","DOI":"10.1371\/journal.pone.0175270","volume":"12","author":"Hwang D.J.","year":"2017","unstructured":"Hwang D.J.; Lee K.M.; Park M.S.; Choi S.H.; Park J.I.; Cho J.H.; Park K.H.; Woo S.J.; Association between diabetic foot ulcer and diabetic retinopathy. PLoS One 2017,12(4),e0175270","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/pdi.1012","volume":"23","author":"Bakker K.","year":"2006","unstructured":"Bakker K.; Abbas Z.; Pendsey S.; Step by step, improving diabetic foot care in the developing world. Pract Diabetes Int 2006,23(8),365-369","journal-title":"Pract Diabetes Int"},{"key":"ref=47","volume":"12","author":"Tulley S","year":"2009","unstructured":"Tulley S; Foster A; van Putten M; Urbancic-Rovan V; Bakker K;  Diabetic foot care training in developing countries: Addressing the skills shortage. The Diabet Foot J 2009,12(1)","journal-title":"The Diabet Foot J"},{"key":"ref=48","volume":"23","author":"Van Netten JJ","year":"2020","unstructured":"Van Netten JJ; Apelqvist J; Bus SA; Hinchliffe RJ; Lipsky BA; Schaper NC;  New IWGDF Guidelines on Prevention and Management of Diabetic Foot Disease released.. 2020;23(1).  Diabetic Foot Journal 2020,23(1)","journal-title":"Diabetic Foot Journal"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.envint.2018.12.065","volume":"124","author":"Kumar M.","year":"2019","unstructured":"Kumar M.; Jaiswal S.; Sodhi K.K.; Shree P.; Singh D.K.; Agrawal P.K.; Shukla P.; Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance. Environ Int 2019,124,448-461","journal-title":"Environ Int"},{"key":"ref=50","first-page":"36","volume":"30","author":"Peter Blume D.","year":"2017","unstructured":"Peter Blume D.; FACFAS, Brittany Ciaramello, DPM, Michelle Kaufman, DPM, and Shane Reynolds, DPM. Top 10 Antibiotics For Managing Diabetic Foot Infections. Podiatry Today 2017,30(8),36-41","journal-title":"Podiatry Today"},{"key":"ref=51","author":"Patel S.","year":"2018","unstructured":"Patel S.; Bernice F.;  StatPearls [Internet]: StatPearls Publishing 2018","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jgar.2018.08.016","volume":"16","author":"Lee T.","year":"2019","unstructured":"Lee T.; Pang S.; Abraham S.; Coombs G.W.; Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future. J Glob Antimicrob Resist 2019,16,36-47","journal-title":"J Glob Antimicrob Resist"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.idc.2018.04.004","volume":"32","author":"Bartoletti M.","year":"2018","unstructured":"Bartoletti M.; Giannella M.; Tedeschi S.; Viale P.; Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients. Infect Dis Clin North Am 2018,32(3),551-580","journal-title":"Infect Dis Clin North Am"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2146\/ajhp080004","volume":"65","author":"Niu S-C.","year":"2008","unstructured":"Niu S-C.; Deng S-T.; Lee M-H.; Ho C.; Chang H-Y.; Liu F-H.; Modified vancomycin dosing protocol for treatment of diabetic foot infections. Am J Health Syst Pharm 2008,65(18),1740-1743","journal-title":"Am J Health Syst Pharm"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00003495-198529020-00002","volume":"29","author":"Richards D.M.","year":"1985","unstructured":"Richards D.M.; Brogden R.N.; Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1985,29(2),105-161","journal-title":"Drugs"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/jac\/12.2.119","volume":"12","author":"Hayes M.V.","year":"1983","unstructured":"Hayes M.V.; Orr D.C.; Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother 1983,12(2),119-126","journal-title":"J Antimicrob Chemother"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1086\/424846","volume":"39","author":"Lipsky B.A.","year":"2004","unstructured":"Lipsky B.A.; Berendt A.R.; Deery H.G.; Embil J.M.; Joseph W.S.; Karchmer A.W.; LeFrock J.L.; Lew D.P.; Mader J.T.; Norden C.; Tan J.S.; Diagnosis and treatment of diabetic foot infections. Clin Infect Dis Infectious Diseases Society of America2004,39(7),885-910","journal-title":"Clin Infect Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","volume":"54","author":"Freeman C.D.","year":"1997","unstructured":"Freeman C.D.; Klutman N.E.; Lamp K.C.; Metronidazole. A therapeutic review and update. Drugs 1997,54(5),679-708","journal-title":"Drugs"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/jac\/31.1.9","volume":"31","author":"Edwards D.I.","year":"1993","unstructured":"Edwards D.I.; Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 1993,31(1),9-20","journal-title":"J Antimicrob Chemother"},{"key":"ref=60","author":"Edwards D.I.","year":"2013","unstructured":"Edwards D.I.; Reduction of nitroimidazoles in vitro and DNA damage. Bioreduction in the Activation of Drugs Proceedings of the Second Biochemical Pharmacology Symposium 2013","journal-title":"Proceedings of the Second Biochemical Pharmacology Symposium"},{"key":"ref=61","author":"Muller M.","year":"2013","unstructured":"Muller M.; Reductive activation of nitroimidazoles in anaerobic microorganisms. Bioreduction in the Activation of Drugs Proceedings of the Second Biochemical Pharmacology Symposium 2013","journal-title":"Proceedings of the Second Biochemical Pharmacology Symposium"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e13006","DOI":"10.1111\/ijcp.13006","volume":"71","author":"Barwell N.D.","year":"2017","unstructured":"Barwell N.D.; Devers M.C.; Kennon B.; Hopkinson H.E.; McDougall C.; Young M.J.; Robertson H.M.A.; Stang D.; Dancer S.J.; Seaton A.; Leese G.P.; Diabetic foot infection: Antibiotic therapy and good practice recommendations. Int J Clin Pract 2017,71(10),e13006","journal-title":"Int J Clin Pract"},{"key":"ref=63","author":"Agwuh K","year":"2012","unstructured":"Agwuh K; Hosker-Diabetologist J.; Skin and Soft Tissue Infection Guideline,  including Diabetic Foot Ulcer Infection 2012","journal-title":"including Diabetic Foot Ulcer Infection"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0025-7125(16)30032-3","volume":"79","author":"Tan J.S.","year":"1995","unstructured":"Tan J.S.; File T.M.; Antipseudomonal penicillins. Med Clin North Am 1995,79(4),679-693","journal-title":"Med Clin North Am"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/ndt\/gfh048","volume":"19","author":"Tong M.K.H.","year":"2004","unstructured":"Tong M.K.H.; Siu Y-P.; Yung C-Y.; Kwan T-H.; Piperacillin\/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrol Dial Transplant 2004,19(5),1341","journal-title":"Nephrol Dial Transplant"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/adc.58.12.1006","volume":"58","author":"Placzek M.","year":"1983","unstructured":"Placzek M.; Whitelaw A.; Want S.; Sahathevan M.; Darrell J.; Piperacillin in early neonatal infection. Arch Dis Child 1983,58(12),1006-1009","journal-title":"Arch Dis Child"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1039\/C6MD00585C","volume":"8","author":"Sarkar P.","year":"2017","unstructured":"Sarkar P.; Yarlagadda V.; Ghosh C.; Haldar J.; A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. MedChemComm 2017,8(3),516-533","journal-title":"MedChemComm"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/AAC.38.1.144","volume":"38","author":"Collins L.A.","year":"1994","unstructured":"Collins L.A.; Wennersten C.B.; Ferraro M.J.; Moellering R.C.; Eliopoulos G.M.; Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp. Antimicrob Agents Chemother 1994,38(1),144-146","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2165\/00003495-199447030-00008","volume":"47","author":"Bryson H.M.","year":"1994","unstructured":"Bryson H.M.; Brogden R.N.; Piperacillin\/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1994,47(3),506-535","journal-title":"Drugs"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0378-1097(97)00013-X","volume":"148","author":"Bonomo R.A.","year":"1997","unstructured":"Bonomo R.A.; Rudin S.A.; Shlaes D.M.; Tazobactam is a potent inactivator of selected inhibitor-resistant class A &#x3B2;-lactamases. FEMS Microbiol Lett 1997,148(1),59-62","journal-title":"FEMS Microbiol Lett"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e00583","DOI":"10.1128\/mBio.00583-18","volume":"9","author":"Schechter L.M.","year":"2018","unstructured":"Schechter L.M.; Creely D.P.; Garner C.D.; Shortridge D.; Nguyen H.; Chen L.; Hanson B.M.; Sodergren E.; Weinstock G.M.; Dunne W.M.; van Belkum A.; Leopold S.R.; Extensive gene amplification as a mechanism for piperacillin-tazobactam resistance in Escherichia coli. MBio 2018,9(2),e00583-e18","journal-title":"MBio"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"19494","DOI":"10.1074\/jbc.M311669200","volume":"279","author":"Pagan-Rodriguez D.","year":"2004","unstructured":"Pagan-Rodriguez D.; Zhou X.; Simmons R.; Bethel C.R.; Hujer A.M.; Helfand M.S.; Jin Z.; Guo B.; Anderson V.E.; Ng L.M.; Bonomo R.A.; Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 ->Gly SHV-1 &#x3B2;-lactamase: insights into the mechanism of inhibition. J Biol Chem 2004,279(19),19494-19501","journal-title":"J Biol Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1128\/AAC.49.10.4368-4371.2005","volume":"49","author":"Legat F.J.","year":"2005","unstructured":"Legat F.J.; Krause R.; Zenahlik P.; Hoffmann C.; Scholz S.; Salmhofer W.; Tscherpel J.; Tscherpel T.; Kerl H.; Dittrich P.; Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection. Antimicrob Agents Chemother 2005,49(10),4368-4371","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/0016-5085(89)91633-8","volume":"96","author":"Reddy K.R.","year":"1989","unstructured":"Reddy K.R.; Brillant P.; Schiff E.R.; Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989,96(4),1135-1141","journal-title":"Gastroenterology"},{"key":"ref=75","author":"Evans J.","year":"2019","unstructured":"Evans J.; Wittler M.;  StatPearls [Internet]: StatPearls Publishing 2019","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2165\/00003495-198122050-00001","volume":"22","author":"Brogden R.N.","year":"1981","unstructured":"Brogden R.N.; Carmine A.; Heel R.C.; Morley P.A.; Speight T.M.; Avery G.S.; Amoxycillin\/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs 1981,22(5),337-362","journal-title":"Drugs"},{"key":"ref=77","first-page":"591","volume":"3","author":"Stein G.E.","year":"1984","unstructured":"Stein G.E.; Gurwith M.J.; Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination. Clin Pharm 1984,3(6),591-599","journal-title":"Clin Pharm"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1128\/AAC.13.3.389","volume":"13","author":"Wise R.","year":"1978","unstructured":"Wise R.; Andrews J.M.; Bedford K.A.; \nin vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin. Antimicrob Agents Chemother 1978,13(3),389-393","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkh050","volume":"53","author":"White AR","year":"2004","unstructured":"White AR; Kaye C; Poupard J; Pypstra R; Woodnutt G; Wynne B; Augmentin&#xAE;(amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother 2004,53(suppl_1),13-120","journal-title":"J Antimicrob Chemother"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1086\/380449","volume":"38","author":"Lipsky B.A.","year":"2004","unstructured":"Lipsky B.A.; Itani K.; Norden C.; Group L.D.F.I.S.; Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate. Clin Infect Dis Linezolid Diabetic Foot Infections Study Group2004,38(1),17-24","journal-title":"Clin Infect Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1155\/1998\/538090","volume":"9","author":"Smieja M.","year":"1998","unstructured":"Smieja M.; Current indications for the use of clindamycin: A critical review. Can J Infect Dis 1998,9(1),22-28","journal-title":"Can J Infect Dis"},{"key":"ref=82","author":"Murphy P.B.","year":"2019","unstructured":"Murphy P.B.; Le J.K.;  StatPearls [Internet]: StatPearls Publishing 2019","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"Liu C.","year":"2011","unstructured":"Liu C.; Bayer A.; Cosgrove S.E.; Daum R.S.; Fridkin S.K.; Gorwitz R.J.; Kaplan S.L.; Karchmer A.W.; Levine D.P.; Murray B.E.; J Rybak M.; Talan D.A.; Chambers H.F.; Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis Infectious Diseases Society of America2011,52(3),e18-e55","journal-title":"Clin Infect Dis"},{"key":"ref=84","author":"Peechakara B.V.","year":"2018","unstructured":"Peechakara B.V.; Gupta M.;  StatPearls [Internet]: StatPearls Publishing 2018","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=85","first-page":"20","volume":"30","author":"Kanra G.","year":"2002","unstructured":"Kanra G.; Experience with ampicillin\/sulbactam in severe infections.  J Internation Med Res 2002,30(1_suppl),20-30","journal-title":"J Internation Med Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2165\/00003495-200767130-00003","volume":"67","author":"Rafailidis P.I.","year":"2007","unstructured":"Rafailidis P.I.; Ioannidou E.N.; Falagas M.E.; Ampicillin\/sulbactam: current status in severe bacterial infections. Drugs 2007,67(13),1829-1849","journal-title":"Drugs"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.3109\/9781420019810","author":"Munshi M.N.","year":"2007","unstructured":"Munshi M.N.; Lipsitz L.A.;  Geriatric diabetes: CRC Press 2007","journal-title":"Geriatric diabetes: CRC Press"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1056\/NEJM199102073240606","volume":"324","author":"Hooper D.C.","year":"1991","unstructured":"Hooper D.C.; Wolfson J.S.; Fluoroquinolone antimicrobial agents. N Engl J Med 1991,324(6),384-394","journal-title":"N Engl J Med"},{"key":"ref=89","author":"Thai T.","year":"2018","unstructured":"Thai T.; Zito P.M.;  StatPearls [Internet]: StatPearls Publishing 2018","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=90","first-page":"553","volume":"73","author":"Peyriere H.","year":"2018","unstructured":"Peyriere H.; Makinson A.; Marchandin H.; Reynes J.; Doxycycline in the management of sexually transmitted infections. J Antimicrob Chemother 2018,73(3),553-563","journal-title":"J Antimicrob Chemother"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s002030050339","volume":"165","author":"Schnappinger D.","year":"1996","unstructured":"Schnappinger D.; Hillen W.; Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol 1996,165(6),359-369","journal-title":"Arch Microbiol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00019048-200201000-00008","volume":"11","author":"Pham P.","year":"2002","unstructured":"Pham P.; Ertapenem (INVANZ): A New Once a Day Carbapenem. Infect Dis Clin Pract 2002,11(1),30-31","journal-title":"Infect Dis Clin Pract"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.2165\/00003495-200565150-00013","volume":"65","author":"Keating G.M.","year":"2005","unstructured":"Keating G.M.; Perry C.M.; Ertapenem: a review of its use in the treatment of bacterial infections. Drugs 2005,65(15),2151-2178","journal-title":"Drugs"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2165\/00003088-200039030-00002","volume":"39","author":"Mouton J.W.","year":"2000","unstructured":"Mouton J.W.; Touzw D.J.; Horrevorts A.M.; Vinks A.A.; Comparative pharmacokinetics of the carbapenems: clinical implications. Clin Pharmacokinet 2000,39(3),185-201","journal-title":"Clin Pharmacokinet"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","volume":"67","author":"Zhanel G.G.","year":"2007","unstructured":"Zhanel G.G.; Wiebe R.; Dilay L.; Thomson K.; Rubinstein E.; Hoban D.J.; Noreddin A.M.; Karlowsky J.A.; Comparative review of the carbapenems. Drugs 2007,67(7),1027-1052","journal-title":"Drugs"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jac\/36.1.53","volume":"36","author":"Sumita Y.","year":"1995","unstructured":"Sumita Y.; Fukasawa M.; Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3. J Antimicrob Chemother 1995,36(1),53-64","journal-title":"J Antimicrob Chemother"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medsci6010001","volume":"6","author":"Codjoe F.S.","year":"2017","unstructured":"Codjoe F.S.; Donkor E.S.; Carbapenem resistance: a review. Med Sci (Basel) 2017,6(1),1","journal-title":"Med Sci (Basel)"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2147\/VHRM.S3162","volume":"5","author":"Edmonds M.","year":"2009","unstructured":"Edmonds M.; The treatment of diabetic foot infections: focus on ertapenem. Vasc Health Risk Manag 2009,5,949-963","journal-title":"Vasc Health Risk Manag"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-11-13","volume":"11","author":"Masadeh M.","year":"2012","unstructured":"Masadeh M.; Mhaidat N.; Alzoubi K.; Al-Azzam S.; Alnasser Z.; Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. Ann Clin Microbiol Antimicrob 2012,11(1),13","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=100","author":"McIver L.A.","year":"2019","unstructured":"McIver L.A.; Siddique M.S.;  StatPearls [Internet]: StatPearls Publishing 2019","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.mehy.2007.03.022","volume":"69","author":"Gulcan E.","year":"2007","unstructured":"Gulcan E.; Gulcan A.; Erbilen E.; Toker S.; Statins may be useful in diabetic foot ulceration treatment and prevention. Med Hypotheses 2007,69(6),1313-1315","journal-title":"Med Hypotheses"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1161\/hc2401.092816","volume":"103","author":"Vasa M.","year":"2001","unstructured":"Vasa M.; Fichtlscherer S.; Adler K.; Aicher A.; Martin H.; Zeiher A.M.; Dimmeler S.; Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001,103(24),2885-2890","journal-title":"Circulation"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1753-0407.2009.00031.x","volume":"1","author":"Johansen O.E.","year":"2009","unstructured":"Johansen O.E.; Birkeland K.I.; J&#xF8;rgensen A.P.; Orvik E.; S&#xF8;rg&#xE5;rd B.; Torjussen B.R.; Ueland T.; Aukrust P.; Gullestad L.; Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial. J Diabetes 2009,1(3),182-187","journal-title":"J Diabetes"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1074\/jbc.M117.811240","volume":"293","author":"Sawaya A.P.","year":"2018","unstructured":"Sawaya A.P.; Pastar I.; Stojadinovic O.; Lazovic S.; Davis S.C.; Gil J.; Kirsner R.S.; Tomic-Canic M.; Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5. J Biol Chem 2018,293(4),1439-1449","journal-title":"J Biol Chem"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jobm.201100614","volume":"53","author":"Farmer A.R.","year":"2013","unstructured":"Farmer A.R.; Murray C.K.; Mende K.; Akers K.S.; Zera W.C.; Beckius M.L.; Yun H.C.; Effect of HMG-CoA reductase inhibitors on antimicrobial susceptibilities for gram-negative rods. J Basic Microbiol 2013,53(4),336-339","journal-title":"J Basic Microbiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"10265","DOI":"10.1074\/jbc.M110.188268","volume":"286","author":"Vukelic S.","year":"2011","unstructured":"Vukelic S.; Stojadinovic O.; Pastar I.; Rabach M.; Krzyzanowska A.; Lebrun E.; Davis S.C.; Resnik S.; Brem H.; Tomic-Canic M.; Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem 2011,286(12),10265-10275","journal-title":"J Biol Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1074\/jbc.M109.016741","volume":"285","author":"Vukelic S.","year":"2010","unstructured":"Vukelic S.; Stojadinovic O.; Pastar I.; Vouthounis C.; Krzyzanowska A.; Das S.; Samuels H.H.; Tomic-Canic M.; Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. J Biol Chem 2010,285(3),1980-1988","journal-title":"J Biol Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1586\/edm.10.60","volume":"5","author":"Stojadinovic O.","year":"2010","unstructured":"Stojadinovic O.; Lebrun E.; Pastar I.; Kirsner R.; Davis S.C.; Tomic- Canic M.; Statins as potential therapeutic agents for healing disorders. Expert Rev Dermatol 2010,5(6),689-698","journal-title":"Expert Rev Dermatol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/01.STR.32.4.980","volume":"32","author":"Amin-Hanjani S.","year":"2001","unstructured":"Amin-Hanjani S.; Stagliano N.E.; Yamada M.; Huang P.L.; Liao J.K.; Moskowitz M.A.; Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 2001,32(4),980-986","journal-title":"Stroke"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.ajpath.2012.08.023","volume":"181","author":"Asai J.","year":"2012","unstructured":"Asai J.; Takenaka H.; Hirakawa S.; Sakabe J.; Hagura A.; Kishimoto S.; Maruyama K.; Kajiya K.; Kinoshita S.; Tokura Y.; Katoh N.; Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis. Am J Pathol 2012,181(6),2217-2224","journal-title":"Am J Pathol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4172\/0975-0851.1000375","volume":"10","author":"Sameh N.","year":"2018","unstructured":"Sameh N.; Aly U.; Abou-Taleb H.; Abdellatif A.; Prospective role of simvastatin on wound healing: review of the literature. J Bioequivalence Bioavailab 2018,10(2),36-42","journal-title":"J Bioequivalence Bioavailab"},{"key":"ref=112","first-page":"263","volume":"13","author":"Khoshneviszadeh M.","year":"2014","unstructured":"Khoshneviszadeh M.; Ashkani-Esfahani S.; Namazi M.R.; Noorafshan A.; Geramizadeh B.; Miri R.; Topical simvastatin enhances tissue regeneration in full-thickness skin wounds in rat models. Iran J Pharm Res 2014,13(1),263-269","journal-title":"Iran J Pharm Res"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5935\/abc.20150123","volume":"105","author":"Gismondi R.A.","year":"2015","unstructured":"Gismondi R.A.; Bedirian R.; Pozzobon C.R.; Ladeira M.C.; Oigman W.; Neves M.F.; Renin-angiotensin system blockade associated with statin improves endothelial function in diabetics. Arq Bras Cardiol 2015,105(6),597-605","journal-title":"Arq Bras Cardiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/sj.bjp.0706420","volume":"146","author":"de Sotomayor M.&#xC1;.","year":"2005","unstructured":"de Sotomayor M.&#xC1;.; P&#xE9;rez-Guerrero C.; Herrrera M.D.; Jimenez L.; Mar&#xED;n R.; Marhuenda E.; Andriantsitohaina R.; Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol 2005,146(8),1130-1138","journal-title":"Br J Pharmacol"},{"key":"ref=115","first-page":"441","volume":"6","author":"Nagasarapu M.","year":"2018","unstructured":"Nagasarapu M.; Simvastatin and its application in wound healing and skin disorders: A review. Pharm Pharmacol Int J 2018,6(6),441-447","journal-title":"Pharm Pharmacol Int J"},{"key":"ref=116","author":"Corcoran C.","year":"2018","unstructured":"Corcoran C.; Jacobs T.F.;  StatPearls [Internet]: StatPearls Publishing 2018","journal-title":"StatPearls [Internet]: StatPearls Publishing"},{"key":"ref=117","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/325851","author":"Ainuddin JA","year":"2015","unstructured":"Ainuddin JA; Karim N; Zaheer S; Ali SS; Hasan AA; Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J Diabet Res 2015","journal-title":"J Diabet Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"e2975","DOI":"10.1002\/dmrr.2975","volume":"34","author":"Malik F.","year":"2018","unstructured":"Malik F.; Mehdi S.F.; Ali H.; Patel P.; Basharat A.; Kumar A.; Ashok F.; Stein J.; Brima W.; Malhotra P.; Roth J.; Is metformin poised for a second career as an antimicrobial? Diabetes Metab Res Rev 2018,34(4),e2975","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"8691","DOI":"10.3892\/mmr.2017.7707","volume":"16","author":"Han X.","year":"2017","unstructured":"Han X.; Tao Y.; Deng Y.; Yu J.; Sun Y.; Jiang G.; Metformin accelerates wound healing in type 2 diabetic db\/db mice. Mol Med Rep 2017,16(6),8691-8698","journal-title":"Mol Med Rep"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"Rena G.","year":"2017","unstructured":"Rena G.; Hardie D.G.; Pearson E.R.; The mechanisms of action of metformin. Diabetologia 2017,60(9),1577-1585","journal-title":"Diabetologia"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jdi.12864","volume":"9","author":"Minamii T.","year":"2018","unstructured":"Minamii T.; Nogami M.; Ogawa W.; Mechanisms of metformin action: In and out of the gut. J Diabetes Investig 2018,9(4),701-703","journal-title":"J Diabetes Investig"},{"key":"ref=122","first-page":"213","volume":"24","author":"Prakash A.","year":"2011","unstructured":"Prakash A.; Managing hyperglycaemia in diabetic foot. JIMSA 2011,24(4),213-215","journal-title":"JIMSA"},{"key":"ref=123","first-page":"27","volume":"4","author":"Karimi A.","year":"2015","unstructured":"Karimi A.; Majlesi M.; Rafieian-Kopaei M.; Herbal versus synthetic drugs; beliefs and facts. J Nephropharmacol 2015,4(1),27-30","journal-title":"J Nephropharmacol"},{"key":"ref=124","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/259412","author":"Jin S","unstructured":"Jin S; Zhang M; Gao Y; Zhang X; Cui G; Zhang Y.; The efficacy of Jing Wan Hong ointment for nerve injury diabetic foot ulcer and its mechanisms. J Diabetes Res 2014; 2014: 259412.","journal-title":"J Diabetes Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ptr.2649","volume":"23","author":"Lau T.W.","year":"2009","unstructured":"Lau T.W.; Chan Y.W.; Lau C.P.; Lau K.M.; Lau C.B.; Fung K.P.; Leung P.C.; Ho Y.Y.; Radix Astragali and Radix Rehmanniae, the principal components of two antidiabetic foot ulcer herbal formulae, elicit viability-promoting effects on primary fibroblasts cultured from diabetic foot ulcer tissues. Phytother Res 2009,23(6),809-815","journal-title":"Phytother Res"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jep.2010.10.040","volume":"133","author":"Li S.","year":"2011","unstructured":"Li S.; Zhao J.; Liu J.; Xiang F.; Lu D.; Liu B.; Xu J.; Zhang H.; Zhang Q.; Li X.; Yu R.; Chen M.; Wang X.; Wang Y.; Chen B.; Prospective randomized controlled study of a Chinese herbal medicine compound Tangzu Yuyang Ointment for chronic diabetic foot ulcers: a preliminary report. J Ethnopharmacol 2011,133(2),543-550","journal-title":"J Ethnopharmacol"},{"key":"ref=127","first-page":"41","volume":"63","author":"Dogan E.","year":"2017","unstructured":"Dogan E.; Yanmaz L.; Gedikli S.; Ersoz U.; Okumus Z.; The effect of pycnogenol on wound healing in diabetic rats. Ostomy Wound Manage 2017,63(4),41-47","journal-title":"Ostomy Wound Manage"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/iwj.12084","volume":"12","author":"Hotkar M.S.","year":"2015","unstructured":"Hotkar M.S.; Avachat A.M.; Bhosale S.S.; Oswal Y.M.; Preliminary investigation of topical nitroglycerin formulations containing natural wound healing agent in diabetes-induced foot ulcer. Int Wound J 2015,12(2),210-217","journal-title":"Int Wound J"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/1389557517666170419114722","volume":"18","author":"AlMatar M.","year":"2018","unstructured":"AlMatar M.; Islam M.R.; Albarri O.; Var I.; Koksal F.; Pomegranate as a possible treatment in reducing risk of developing wound healing, obesity, neurodegenerative disorders, and diabetes mellitus. Mini Rev Med Chem 2018,18(6),507-526","journal-title":"Mini Rev Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1177\/0300060518769529","volume":"46","author":"Jia H.","year":"2018","unstructured":"Jia H.; Yang B.; Li Y.; Liang C.; Lu H.; Lin D.; Ju S.; Chinese medicine ulcer oil promotes the healing of diabetic foot ulcers. J Int Med Res 2018,46(7),2679-2686","journal-title":"J Int Med Res"},{"key":"ref=131","first-page":"45","volume":"7","author":"Mahboubi M.","year":"2018","unstructured":"Mahboubi M.; Taghizadeh M.; Khamechian T.; Tamtaji O.R.; Mokhtari R.; Talaei S.A.; The Wound Healing Effects of Herbal Cream Containing Oliveria Decumbens and Pelargonium Graveolens Essential Oils in Diabetic Foot Ulcer Model. World J Plast Surg 2018,7(1),45-50","journal-title":"World J Plast Surg"},{"key":"ref=132","first-page":"2091","volume":"39","author":"Guo J.","year":"2014","unstructured":"Guo J.; Meng Q-H.; Yin Q-Y.; Lin C.; Ma Z.; Xu B.; Qian X.; Bao D.Q.; Zhang Y.Y.; Zhang Q.C.; Bian H.M.; Hu X.Y.; [Study of effect of tongsaimai tablets on experimental diabetic foot model rats]. Zhongguo Zhongyao Zazhi 2014,39(11),2091-2096","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=133","first-page":"399","volume":"17","author":"Li W.","year":"2018","unstructured":"Li W.; Kandhare A.D.; Mukherjee A.A.; Bodhankar S.L.; Hesperidin, a plant flavonoid accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats: Role of TGF-&#xDF;\/Smads and Ang-1\/Tie-2 signaling pathways. EXCLI J 2018,17,399-419","journal-title":"EXCLI J"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s12906-017-1930-x","volume":"17","author":"Tuhin R.H.","year":"2017","unstructured":"Tuhin R.H.; Begum M.M.; Rahman M.S.; Karim R.; Begum T.; Ahmed S.U.; Mostofa R.; Hossain A.; Abdel-Daim M.; Begum R.; Wound healing effect of Euphorbia hirta linn. (Euphorbiaceae) in alloxan induced diabetic rats. BMC Complement Altern Med 2017,17(1),423","journal-title":"BMC Complement Altern Med"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/ijmm.2015.2292","volume":"36","author":"Zeng Z.","year":"2015","unstructured":"Zeng Z.; Huang W.D.; Gao Q.; Su M.L.; Yang Y.F.; Liu Z.C.; Zhu B.H.; Arnebin-1 promotes angiogenesis by inducing eNOS, VEGF and HIF-1&#x3B1; expression through the PI3K-dependent pathway. Int J Mol Med 2015,36(3),685-697","journal-title":"Int J Mol Med"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cjtee.2016.10.004","volume":"20","author":"Kittana N.","year":"2017","unstructured":"Kittana N.; Abu-Rass H.; Sabra R.; Manasra L.; Hanany H.; Jaradat N.; Hussein F.; Zaid A.N.; Topical aqueous extract of Ephedra alata can improve wound healing in an animal model. Chin J Traumatol 2017,20(2),108-113","journal-title":"Chin J Traumatol"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/jomfp.JOMFP_237_13","volume":"22","author":"Puspasari A.","year":"2018","unstructured":"Puspasari A.; Harijanti K.; Soebadi B.; Hendarti H.T.; Radithia D.; Ernawati D.S.; Effects of topical application of propolis extract on fibroblast growth factor-2 and fibroblast expression in the traumatic ulcers of diabetic Rattus norvegicus.\n J Oral Maxillofac Pathol 2018,22(1),54-58","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref=138","first-page":"583","volume":"15","author":"Mansouri E.","year":"2016","unstructured":"Mansouri E.; Hardani A.; Afzalzadeh M.R.; Amir Zargar A.; Meamar Z.; Combined effects of retinoic acid and hydro-alcoholic extract of Rosa damascena mill on wound in diabetic rats. Iranian journal of pharmaceutical research. Iran J Pharm Res 2016,15(2),583-589","journal-title":"Iran J Pharm Res"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12906-015-0745-x","volume":"15","author":"Perini J.A.","year":"2015","unstructured":"Perini J.A.; Angeli-Gamba T.; Alessandra-Perini J.; Ferreira L.C.; Nasciutti L.E.; Machado D.E.; Topical application of Acheflan on rat skin injury accelerates wound healing: a histopathological, immunohistochemical and biochemical study. BMC Complement Altern Med 2015,15(1),203","journal-title":"BMC Complement Altern Med"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12906-015-0878-y","volume":"15","author":"Mulisa E.","year":"2015","unstructured":"Mulisa E.; Asres K.; Engidawork E.; Evaluation of wound healing and anti-inflammatory activity of the rhizomes of Rumex abyssinicus J. (Polygonaceae) in mice. BMC Complement Altern Med 2015,15(1),341","journal-title":"BMC Complement Altern Med"},{"key":"ref=141","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7475124","author":"Maurya H","year":"2016","unstructured":"Maurya H; Semwal M; Dubey SK; Pharmacological evaluation of Chrozophora tinctoria as wound healing potential in diabetic rat\u2019s model. BioMed research international 2016","journal-title":"BioMed research international"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-8520.146216","volume":"35","author":"Bhat K.S.","year":"2014","unstructured":"Bhat K.S.; Vishwesh B.N.; Sahu M.; Shukla V.K.; A clinical study on the efficacy of Panchavalkala cream in Vrana Shodhana w.s.r to its action on microbial load and wound infection. Ayu 2014,35(2),135-140","journal-title":"Ayu"},{"key":"ref=143","author":"Yadollah-Damavandi S","year":"2015","unstructured":"Yadollah-Damavandi S; Chavoshi-Nejad M; Jangholi E; Nekouyian N; Hosseini S; Seifaee A; Topical Hypericum perforatum improves tissue regeneration in full-thickness excisional wounds in diabetic rat model. Evidence-Based Complemen and Alter Med 2015","journal-title":"Evidence-Based Complemen and Alter Med"},{"key":"ref=144","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7931314","author":"Zhao Y","year":"2016","unstructured":"Zhao Y; Yu J; Liu J; An X.; The role of Liuwei Dihuang Pills and Ginkgo leaf tablets in treating diabetic complications.  Evidence-Based Complementary and Alternative Medicine 2016","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"ref=145","author":"Routes A.E.","year":"2019","unstructured":"Routes A.E.; Drug Absorption Distribution And Elimination; Pharmacokinetics 2019","journal-title":"Distribution And Elimination; Pharmacokinetics"},{"key":"ref=146","author":"Bharath S.","year":"2013","unstructured":"Bharath S.; Pharmaceutical technology: Concepts and applications: Pearson Education India 2013"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/17425247.2015.1060218","volume":"12","author":"Lopez F.L.","year":"2015","unstructured":"Lopez F.L.; Ernest T.B.; Tuleu C.; Gul M.O.; Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin Drug Deliv 2015,12(11),1727-1740","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=148","first-page":"970","volume":"4","author":"Bhagwat R.","year":"2013","unstructured":"Bhagwat R.; Vaidhya I.; Novel drug delivery systems: An overview. Int J Pharm Sci Res 2013,4(3),970","journal-title":"Int J Pharm Sci Res"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187449\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/187449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T03:54:13Z","timestamp":1648698853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187449\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":148,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399816999201102125537","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}